Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.provenanceINTA-
dc.contributorThiry, Etienne-
dc.contributorDal Pozzo, Fabiana-
dc.contributorBarrandeguy, Maria Edith-
dc.contributorVissani, Aldana-
dc.creatorThiry, Etienne-
dc.creatorDal Pozzo, Fabiana-
dc.creatorBarrandeguy, Maria Edith-
dc.creatorVissani, Aldana-
dc.date2017-09-14T14:20:56Z-
dc.date2017-09-14T14:20:56Z-
dc.date2016-
dc.date.accessioned2019-04-29T16:27:02Z-
dc.date.available2019-04-29T16:27:02Z-
dc.date.issued2017-09-14T14:20:56Z-
dc.date.issued2017-09-14T14:20:56Z-
dc.date.issued2016-
dc.identifier1090-0233-
dc.identifierhttps://doi.org/10.1016/j.tvjl.2015.06.010-
dc.identifierhttp://hdl.handle.net/20.500.12123/1220-
dc.identifierhttp://www.sciencedirect.com/science/article/pii/S1090023315002543-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/313484-
dc.descriptionEquid herpesvirus infections cause respiratory, neurological and reproductive syndromes. Despite preventive and control measures and the availability of vaccines and immunostimulants, herpesvirus infections still constitute a major threat to equine health and for the equine industry worldwide. Antiviral drugs, particularly nucleoside analogues and foscarnet, are successfully used for the treatment of human alphaherpesvirus infections. In equine medicine, the use of antiviral medications in alphaherpesvirus infections would decrease the excretion of virus and diminish the risk of contagion and the convalescent time in affected horses, and would also improve the clinical outcome of equine herpesvirus myeloencephalopathy. The combined use of antiviral compounds, along with vaccines, immune modulators, and effective preventive and control measures, might be beneficial in diminishing the negative impact of alphaherpesvirus infections in horses. The purpose of this review is to analyse the available information regarding the use of antiviral agents against alphaherpesviruses, with particular emphasis on equine alphaherpesvirus infections.-
dc.descriptionInst.de Virología-
dc.formatapplication/pdf-
dc.languageeng-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.sourceThe Veterinary Journal 207 : 38-44 (January 2016)-
dc.sourcereponame:INTA Digital (INTA)-
dc.sourceinstname:Instituto Nacional de Tecnología Agropecuaria-
dc.sourceinstacron:INTA-
dc.source.uri1090-0233-
dc.source.urihttps://doi.org/10.1016/j.tvjl.2015.06.010-
dc.source.urihttp://hdl.handle.net/20.500.12123/1220-
dc.source.urihttp://www.sciencedirect.com/science/article/pii/S1090023315002543-
dc.source.urihttps://doi.org/10.1016/j.tvjl.2015.06.010-
dc.source.urihttp://hdl.handle.net/20.500.12123/1220-
dc.source.urihttp://www.sciencedirect.com/science/article/pii/S1090023315002543-
dc.subjectEnfermedades de los Animales-
dc.subjectViricidas-
dc.subjectAlphavirus-
dc.subjectHerpesviridae-
dc.subjectAnimal Diseases-
dc.subjectAntiviral Agents-
dc.subjectHerpesvirus-
dc.subjectAlphaherpesvirus-
dc.titleAntiviral agents against equid alphaherpesviruses : current status and perspectives-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: INTA

Ficheros en este ítem:
No hay ficheros asociados a este ítem.